Citadel Advisors »

Rigel Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $265k 32k 8.22

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals